Furthermore, results from clinical cancer patients showed that CD4/CD8 ratios were strongly positively correlated with the advanced tumor stage, large tumor sizes and positive lymph node status, but negatively correlated with RFS and OS. This evidence concerns the gene CD8A and cancer.